402 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Kelsen
    Kelsen
  4. Seidman
    Seidman
  5. Motzer
    Motzer
  6. Saltz
    Saltz
  7. Aghajanian
    Aghajanian
  8. Spriggs
    Spriggs
  9. Kemeny
    Kemeny
  10. Kris
    Kris

Groups

  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  8. Epidemiology and Biostatistics (49)
  9. Center for Pancreatic Cancer Research (44)
  10. Hematologic Malignancies, Division of (44)
  1. "drug administration schedule"
Formats
  1. Journal Article (392)
  2. Conference Paper (10)
Groups
  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)

More Groups

People
  1. Clifford Hudis (32)
  2. Larry Norton (30)
  3. Andrew Seidman (25)
  4. David Kelsen (25)
  5. Nancy Kemeny (24)
  6. Robert Motzer (24)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (7)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Cancer (34)
  3. Clinical Cancer Research (23)
  4. Seminars in Oncology (18)
  5. Gynecologic Oncology (16)
  6. JNCI: Journal of the National Cancer Institute (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (62)
  3. Wiley Blackwell (39)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (27)
  6. Springer (26)

More Publishers

Results (402)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: Results of a phase II trial
    Journal Article

    Cohen, A. D.; Zhou, P.; Chou, J.; Teruya-Feldstein, J.; Reich, L.; Hassoun, H.; Levine, B.; Filippa, D. A.; Riedel, E.; Kewalramani, T.; more...
    British Journal of Haematology (2007)

    Fulltext@MSK | Save
  • A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Rizvi, N. A.; Kris, M. G.; Dunne, M.; Farmer, A.; Pizzo, B.; Tyson, L.; Seeger, T.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas
    Journal Article

    Aghajanian, C.; Burris, H. A. 3rd; Jones, S.; Spriggs, D. R.; Cohen, M. B.; Peck, R.; Sabbatini, P.; Hensley, M. L.; Greco, F. A.; Dupont, J.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Cutaneous reactions to chemotherapy and their management
    Journal Article

    Wyatt, A. J.; Leonard, G. D.; Sachs, D. L.
    American Journal of Clinical Dermatology (2006)

    Fulltext@MSK | Save
  • The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma
    Journal Article

    Toner, L. E.; Vrhovac, R.; Smith, E. A.; Gardner, J.; Heaney, M.; Gonen, M.; Teruya-Feldstein, J.; Sirotnak, F.; O'Connor, O. A.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • The Norton - Simon hypothesis: Designing more effective and less toxic chemotherapeutic regimens
    Journal Article

    Simon, R.; Norton, L.
    Nature Clinical Practice Oncology (2006)

    Fulltext@MSK | Save
  • Planned treatment interruptions and chemotherapy-free intervals in the treatment of metastatic colorectal cancer: Time to start stopping?
    Journal Article

    Saltz, L.
    Seminars in Oncology (2006)

    Fulltext@MSK | Save
  • A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma
    Journal Article

    Ronnen, E. A.; Kondagunta, G. V.; Ishill, N.; Sweeney, S. M.; DeLuca, J. K.; Schwartz, L.; Bacik, J.; Motzer, R. J.
    Investigational New Drugs (2006)

    Fulltext@MSK | Save
  • Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: A phase I trial
    Journal Article

    Omuro, A. M.; Raizer, J. J.; Demopoulos, A.; Malkin, M. G.; Abrey, L. E.
    Journal of Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: Multivariate analysis of prognostic factors
    Journal Article

    Nisticò€, C.; Cuppone, F.; Bria, E.; Fornier, M.; Giannarelli, D.; Mottolese, M.; Novelli, F.; Natoli, G.; Cognetti, F.; Terzoli, E.
    Anti-Cancer Drugs (2006)

    Fulltext@MSK | Save